申请人:Garcia Gabriel
公开号:US20100204219A1
公开(公告)日:2010-08-12
The invention relates to novel compounds of formula (I) wherein X, Y, Z represent independently from one another C or N, n stands for 1, 2, 3, m is 0 or 1, p stands for 0 or an integer from 1 to 6, R
1
, R
2
represent independently from one another hydrogen, a halogen atom, a hydroxyl group, a C
1
-C
3
alkyl group and a C
1
-C
3
alkoxy group, R
3
represents, independently from one another if p is not 0, hydrogen, halogen, a C
1
-C
5
linear or branched alkyl, a carboxylyl, a carbomethoxyl, carboethoxyl, a benzyl, an acyl, a hydroxyl, a C
1
-C
4
linear or branched alkoxyl, a trifluoromethyl, a cyano, a morpholino, a 1,3-dioxolyl, an N-acetylamidyl or an amidoyl group, a saturated 5-8 membered ring, a heterocyclic ring, optionally substituted by a C
1
-C
3
alkyl, a hydroxyl or a benzyl group, a C
1
-C
6
alkylsulfonyl, a mono or disubstituted C
1
-C
5
alkyl group, a branched or a cyclic amine, R
6
is H or part of a alicyclic, heteroalicyclic ring system, if m is 0 then C represents CF
3
or a branched or unbranched C
1
-C
4
alkyl group, if m=1 then C represents —CH
2
—O—, —CH
2
—, —CH
2
CH
2
—, —CH
2
CH
2
CH
2
—, —CH
2
(CH
2
)CH
2
— or denotes a chemical bond between N—C or C—C, the CONR
6
group may be linked to C either via its carbon or via its nitrogen atom, CYC stands for a by R
3
substituted or unsubstituted phenyl, pyridinyl, naphthyl, quinolinyl, isoquinolinyl, isoxaxolinyl, thiophenyl,
1,3,4
-thiadiazazolidinyl, furanyl, tetrahydroquinolinyl, tetrahydroisoquinolinyl, morpholinyl, furanyl, cyclohexenyl, and chromen-2-on-yl and its use as a medicament for the treatment of cancer.